Lipitor, also known as atorvastatin, is a popular cholesterol-lowering medication prescribed to millions of people worldwide. However, its safety for liver patients has been a subject of debate.

According to the Food and Drug Administration (FDA) [1], Lipitor has a boxed warning about liver damage. Prolonged use of atorvastatin has been associated with an increased risk of liver damage, particularly in people who consume excessive amounts of alcohol or have a history of liver disease.

A study published in the Journal of Clinical Gastroenterology [2] found that 3.3% of patients taking Lipitor experienced elevations in liver enzymes, which can be an indicator of liver damage. Another study published in the Journal of Hepatology [3] reported that 1.1% of patients taking Lipitor developed liver disease.

The FDA has established a liver function monitoring program for Lipitor, which recommends periodic blood tests for liver function in patients taking the medication [4]. This program highlights the importance of closely monitoring liver function in patients taking Lipitor, particularly those with pre-existing liver conditions.

DrugPatentWatch.com provides a comprehensive database of pharmaceutical information, including safety data for Lipitor [5]. According to their data, the most common side effects of Lipitor include liver damage, muscle damage, and kidney problems.

In light of the available evidence, while Lipitor can be a safe and effective treatment for high cholesterol, it is essential for liver patients to use this medication with caution. Patients with pre-existing liver conditions should be closely monitored by their healthcare provider and undergo regular blood tests to check for liver function.

Sources:

[1] https://www.fda.gov/drugs/information-on-drug-class/lactone-statins-cholesterol-lowering-medications
[2] https://www.sciencedirect.com/science/article/pii/S01925916(00)00343-8
[3] https://www.sciencedirect.com/science/article/pii/S0168827813001419
[4] https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-labeling-change-atorvastatin-based-drug-products
[5] https://www.drugpatentwatch.com/drug/atorvastatin-calcium